← All indications
Heart Failure, Diastolic
Heart failure caused by abnormal myocardial relaxation during DIASTOLE leading to defective cardiac filling.
Drugs by status
Phase 4 trials (42)
- simvastatin
- ezetimibe
- ferric derisomaltose
- benzbromarone
- ambrisentan
- exenatide
- empagliflozin
- ferric carboxymaltose
- liraglutide
- amlodipine
- rosuvastatin
- iloprost
- irbesartan
- levosimendan
- nebivolol
- nesiritide
- febuxostat
- colchicine
- valsartan
- ranolazine
- sotagliflozin
- ertugliflozin
- spironolactone
- furosemide
- ramipril
- carvedilol
- eplerenone
- metoprolol
- sildenafil
- bumetanide
- +12 more
Phase 3 trials (14)
Phase 2 trials (48)
- allopurinol
- riociguat
- alagebrium
- amyl nitrite
- atrial natriuretic peptide
- beetroot juice
- d-ribose
- gadoteric acid
- ivabradine
- Tovinontrine
- ketone
- macitentan
- mangafodipir trisodium
- perhexiline
- pine bark extract
- potassium chloride
- sitagliptin
- salsalate
- semaglutide
- sitaxentan
- nicotinamide
- regress-hfpef
- human placental derived stem cells
- iw-1973
- cilostazol
- verinurad
- liothyronine
- anakinra
- sulforaphane
- propionylcarnitine
- +18 more
Phase 1 trials (15)
Organizations
Organization Involved with Phase 4 Indications (14)
- Astellas
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of General Medical Sciences (NIGMS)
- Baylor University
- Case Western Reserve University
- Johns Hopkins University
- University of Florida
- University of Rochester
- University of Copenhagen
- Vanderbilt University
- Government of Russia
- National Taiwan University
- University of Texas at Houston
- Department of Veteran Affairs
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (16)
- Scios
- Gilead Sciences
- AstraZeneca
- Synvista Therapeutics, Inc
- University of Pennsylvania
- University of Pittsburgh
- Cedars-Sinai Medical Center
- Onze Lieve Vrouw Hospital
- Postgraduate Institute of Medical Education and Research
- University of Kansas
- University of Michigan
- University of South Carolina
- University of Aberdeen
- Medical University of South Carolina
- Cardiovascular Clinical Studies, Inc.
- National University of Ireland
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (9)